Hayakawa I - Search Results

1

Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis.

Hayakawa I, Sato S, Echigo T, Shirasaki F, Hasegawa M, Takehara K. Hayakawa I, et al. Clin Rheumatol. 2004 Aug;23(4):345-7. doi: 10.1007/s10067-004-0876-9. Epub 2004 Apr 9. Clin Rheumatol. 2004. PMID: 15293097

2

Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.

Sato S, Fujimoto M, Hasegawa M, Komura K, Yanaba K, Hayakawa I, Matsushita T, Takehara K. Sato S, et al. Among authors: hayakawa i. Rheumatology (Oxford). 2004 Oct;43(10):1261-6. doi: 10.1093/rheumatology/keh303. Epub 2004 Jul 20. Rheumatology (Oxford). 2004. PMID: 15266059

3

Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.

Nishijima C, Hayakawa I, Matsushita T, Komura K, Hasegawa M, Takehara K, Sato S. Nishijima C, et al. Among authors: hayakawa i. Clin Exp Immunol. 2004 Nov;138(2):357-63. doi: 10.1111/j.1365-2249.2004.02615.x. Clin Exp Immunol. 2004. PMID: 15498049 Free PMC article.

4

Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.

Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S. Hayakawa I, et al. Rheumatology (Oxford). 2005 Jul;44(7):873-8. doi: 10.1093/rheumatology/keh625. Epub 2005 Mar 29. Rheumatology (Oxford). 2005. PMID: 15797972

5

Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma.

Hasegawa M, Fujimoto M, Hayakawa I, Matsushita T, Nishijima C, Yamazaki M, Takehara K, Sato S. Hasegawa M, et al. Among authors: hayakawa i. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):19-24. Clin Exp Rheumatol. 2006. PMID: 16539814

6

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.

Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. Among authors: hayakawa i. J Invest Dermatol. 2003 Apr;120(4):542-7. doi: 10.1046/j.1523-1747.2003.12097.x. J Invest Dermatol. 2003. PMID: 12648215 Free article.

7

A case of scleroderma spectrum disorder with anticentriole antibody and pulmonary hypertension.

Hayakawa I, Sato S, Hasegawa M, Echigo T, Takehara K. Hayakawa I, et al. Clin Rheumatol. 2004 Jun;23(3):266-8. doi: 10.1007/s10067-004-0871-1. Epub 2004 Apr 14. Clin Rheumatol. 2004. PMID: 15168160

8

Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.

Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S. Kodera M, et al. Among authors: hayakawa i. J Rheumatol. 2005 Apr;32(4):629-36. J Rheumatol. 2005. PMID: 15801017

9

Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports.

Hayakawa I, Shirasaki F, Hirano T, Oishi N, Hasegawa M, Sato S, Takehara K. Hayakawa I, et al. Rheumatol Int. 2006 Jan;26(3):270-3. doi: 10.1007/s00296-005-0613-y. Epub 2005 May 25. Rheumatol Int. 2006. PMID: 15915331

10

Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.

Hayakawa I, Hasegawa M, Takehara K, Sato S. Hayakawa I, et al. Arch Dermatol Res. 2005 Oct;297(4):180-3. doi: 10.1007/s00403-005-0603-7. Epub 2005 Oct 26. Arch Dermatol Res. 2005. PMID: 16180014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters